Lawmakers and Advocates Express Outrage at FDA Panel's Decision on MDMA Therapy
Thursday, 6 June 2024, 17:14
'Dead Wrong': Outcry over FDA Panel's Rejection of MDMA Therapy
Lawmakers and advocates are expressing strong disapproval over the recent rejection of using MDMA-assisted therapy by an FDA panel. The decision has sparked controversy and raised concerns about the future of innovative treatment options.
Despite calls for reconsideration, the FDA panel's stance on the therapy remains unchanged, prompting a heated debate within the medical community.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.